This series on “Bacterial Contamination of Platelet Concentrates” is edited by Dr. Sandra Ramirez-Arcos from Canadian Blood Services and University of Ottawa, Canada.
The PGDprime immunoassay for detection of bacterial contamination in platelet concentrates: sensitivity and specificity
FDA guidance on bacterial contamination risk control strategies to enhance the safety and availability of platelets: advantages and limitations
Rapid detection of bacterial contaminants in platelet concentrates using the next generation BACT/ALERT® VIRTUO®; Microbial Detection System: improved safety and operational efficiency
Bacterial mitigation strategies: impact of pathogen reduction and large-volume sampling on platelet productivity
THERAFLEX ultraviolet C (UVC)-based pathogen reduction technology for bacterial inactivation in blood components: advantages and limitations
Transfusion transmitted bacterial infections (TTBI) involving contaminated platelet concentrates: residual risk despite intervention strategies
The series “Bacterial Contamination of Platelet Components” was commissioned by the editorial office, Annals of Blood without any sponsorship or funding. Sandra Ramirez-Arcos served as the unpaid Guest Editor for the series.